Pharmaceuticals North America

North America Whole Genome Sequencing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

North America Whole Genome Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.50 Bn Placeholder estimate
Estimate 2025 $1.76 Bn 50.5% of the global market
Projected 2034 $7.16 Bn 307.7% Adds $5.41 Bn over 9 forecast years
CAGR 2025–2034 16.9% Faster than 82% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • North America is 50.47% of the global market.
  • Among regions, the largest is North America (this report) at $1.76 Bn.
  • Fastest growing: Africa at 19.4% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$5.41 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Whole Genome Sequencing Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.50 Bn — —
2025 (base) $1.76 Bn +$254.0 Mn —
2026 (forecast) $2.05 Bn +$296.9 Mn +16.9%
2027 (forecast) $2.40 Bn +$347.1 Mn +36.7%
2028 (forecast) $2.81 Bn +$405.7 Mn +59.8%
2029 (forecast) $3.28 Bn +$474.3 Mn +86.7%
2030 (forecast) $3.84 Bn +$554.5 Mn +118.3%
2031 (forecast) $4.48 Bn +$648.2 Mn +155.2%
2032 (forecast) $5.24 Bn +$757.7 Mn +198.3%
2033 (forecast) $6.13 Bn +$885.8 Mn +248.8%
2034 (forecast) $7.16 Bn +$1.04 Bn +307.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Whole Genome Sequencing Market Analysis at a glance
Market size, 2025$1.76 Bn placeholder estimate
Forecast, 2034$7.16 Bn placeholder estimate
Growth (CAGR), 2025–203416.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersIllumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Whole Genome Sequencing Market Analysis Executive Summary

Whole genome sequencing reads a person's entire DNA code, used for rare disease diagnosis, cancer, research and population health.

Key segments of the whole Genome Sequencing market include product (Instruments, Consumables and Services) and application (Rare Disease Diagnosis, Oncology and Population Genomics).

Bar chart: North America Whole Genome Sequencing market size, 2024–2034, placeholder estimates. $1.50 Bn in 2024, $1.76 Bn in 2025 and $7.16 Bn in 2034, 16.9% CAGR.
North America Whole Genome Sequencing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Whole Genome Sequencing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the whole Genome Sequencing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the whole Genome Sequencing market.

Competitive Landscape for Whole Genome Sequencing Market in North America

The whole Genome Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Whole Genome Sequencing Market in North America

Whole Genome Sequencing in North America: rules and payment

In the countries we cover here, medicines are approved by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4].

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for whole Genome Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Whole Genome Sequencing right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Whole Genome Sequencing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Whole Genome Sequencing market in North America?
Placeholder estimate: about $1.76 Bn in 2025, rising to about $7.16 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Whole Genome Sequencing market in North America growing?
Placeholder estimate: about 16.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Whole Genome Sequencing market report cover?
The report splits the market by product (Instruments, Consumables, Services, Data Analysis), application (Rare Disease Diagnosis, Oncology, Population Genomics, Research) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Whole Genome Sequencing market?
Key players include Illumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies and Element Biosciences.
What is driving the Whole Genome Sequencing market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.
How much research is published on Whole Genome Sequencing?
PubMed lists 29,479 papers on Whole Genome Sequencing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in North America

See all

Related on genomics

See the topic